I construct charts to help people capitalize on the excess fear and greed of global investors.
My goal: provide research to help investors enlarge their portfolios regardless of market direction. My approach - TBNM or Tops, Bottoms, No Middles
Brian Marckx is the Senior Medical Device Analyst with Zacks Investment Research. Prior to joining Zacks, Brian worked as a high-yield bond analyst on Wachovia Securities' institutional trading desks.
Renaissance Capital provides pre-IPO research and global IPO market analytics to institutional investors. The firm manages portfolios of unseasoned equities through the Global IPO Fund (IPOSX), the Renaissance IPO ETF (IPO) and institutional SMAs.